Takeda completes TiGenix acquisition — 4 insights

Takeda completed its squeeze-out of TiGenix, acquiring complete control of the company.

Here's what you should know:

1. Takeda began its squeeze-out July 6, ending it July 26.

2. Takeda acquired a total of 9,532,694 ordinary shares. About 22,500 warrants were tendered into the squeeze-out.

3. Takeda began paying for the securities Aug. 1.

4. TiGenix will no longer be traded on the U.S. Securities and Exchange Commission. The company was delisted from the Nasdaq July 26.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast